NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Vericel Corporation (NASDAQ: VCEL)

 
VCEL Technical Analysis
1.5
As on 9th Jun 2023 VCEL STOCK Price closed @ 34.96 and we RECOMMEND Buy for LONG-TERM with Stoploss of 30.16 & Sell for SHORT-TERM with Stoploss of 36.94 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

VCELSTOCK Price

Open 33.85 Change Price %
High 35.78 1 Day 1.11 3.28
Low 33.65 1 Week 2.84 8.84
Close 34.96 1 Month 4.20 13.65
Volume 386300 1 Year -4.89 -12.27
52 Week High 43.29 | 52 Week Low 17.65
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
VCEL
Daily Charts
VCEL
Intraday Charts
Whats New @
Bazaartrend
VCEL
Free Analysis
 
VCEL Important Levels Intraday
RESISTANCE39.06
RESISTANCE37.75
RESISTANCE36.93
RESISTANCE36.12
SUPPORT33.80
SUPPORT32.99
SUPPORT32.17
SUPPORT30.86
 
VCEL Forecast May 2024
4th UP Forecast51.11
3rd UP Forecast45.93
2nd UP Forecast42.73
1st UP Forecast39.53
1st DOWN Forecast30.39
2nd DOWN Forecast27.19
3rd DOWN Forecast23.99
4th DOWN Forecast18.81
 
VCEL Weekly Forecast
4th UP Forecast42.36
3rd UP Forecast39.99
2nd UP Forecast38.52
1st UP Forecast37.05
1st DOWN Forecast32.87
2nd DOWN Forecast31.40
3rd DOWN Forecast29.93
4th DOWN Forecast27.56
 
VCEL Forecast2024
4th UP Forecast85.99
3rd UP Forecast69.62
2nd UP Forecast59.51
1st UP Forecast49.39
1st DOWN Forecast20.53
2nd DOWN Forecast10.41
3rd DOWN Forecast0.3
4th DOWN Forecast-16.07
 
 
VCEL Other Details
Segment EQ
Market Capital 2381455360.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
VCEL Address
VCEL
 
VCEL Latest News
 
Your Comments and Response on Vericel Corporation
 
VCEL Business Profile
Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures, and distributes cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product includes, NexoBrid, a registration-stage biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts. Address: 64 Sidney Street, Cambridge, MA, United States, 02139
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service